Nov 5 - Britain's FTSE 100 index is seen opening 2 points lower at 5,581 on Thursday, according to financial bookmakers. * ASTRAZENECA: Chilean President Sebastian Pinera said the country's health regulator had given the go-ahead for clinical trials of AstraZeneca PLC's COVID-19 vaccine. * SAINSBURY: British supermarket group Sainsbury will announce plans to cut 3,000 jobs, alongside its first-half results on Thursday, The Times reported. * BARCLAYS: A former Barclays trader, who fled to his native France before being convicted in London of helping rig Euribor interest rates, has won a court battle against extradition to Britain to serve an eight-year jail sentence, his lawyer said. * GOLD: Gold firmed as investors were cautiously optimistic Democrat Joe Biden would edge past President Donald Trump in a tight race to the White House, boosting the likelihood of more economic stimulus. * OIL: Oil dropped as Democrat Joe Biden edged closer to the White House but the Republicans look likely to retain Senate control, decreasing the chances of any huge COVID-19 relief package. * The UK blue-chip index closed 1.7% higher on Wednesday as a weaker pound boosted shares of exporters, although investors remained cautious on prospects of a contested outcome to the U.S. presidential elections. * UK CORPORATE DIARY: Tate & Lyle Plc HY results RDI Reit Plc FY trading statement Biffa Plc HY earnings Wincanton Plc HY earnings Derwent London Plc Q3 business update Kin and Carta Plc FY earnings AVEVA Group Plc HY earnings AstraZeneca Plc Q3 earnings RSA Insurance Group Plc Q3 trading statement J Sainsbury Plc HY earnings Lancashire Holdings Ltd Q3 trading statement Auto Trader Group Plc HY earnings Trainline Plc HY earnings Inchcape Plc Q3 trading statement Hikma Pharmaceuticals Plc Trading statement RDI Reit Plc FY earnings * For more on the factors affecting European stocks, please click on: TODAY'S UK PAPERS > Financial Times > Other business headlines (Reporting by Priyanshi Mandhan; Editing by Shailesh Kuber)
Our Standards: The Thomson Reuters Trust Principles.